Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Research Article Volume 7 Issue 11

Evaluation of Breast Lump: Comparison of Ultra-Sonographic and CT USG-Guided Histopathological Findings

Tariqul Islam1*, Bidoura Tanim2, Asaduzzaman3, Farhana Kamal Kumu4, Syed Mohammad Sajjad Jalal5, Al Asma Ul Taslima6 and Nadira Parvin7

1Associate Professor, Department of Radiology and Imaging, Sheikh Hasina National Institute of Burn and Plastic Surgery, Dhaka
2Associate Professor, Radiology and imaging Sheikh Hasina National Institute of Burn and Plastic Surgery, Dhaka
3Assistant Professor, Histopathology, Sheikh Hasina National Institute of Burn and Plastic Surgery, Dhaka
4Junior Consultant, Sheikh Hasina National Institute of Burn and Plastic Surgery, Dhaka
5Assistant Professor, Sheikh Hasina National, Institute of Burn and Plastic Surgery, Dhaka
6Junior Consultant, Sheikh Hasina National Institute of Burn and Plastic Surgery, Dhaka
7Senior Lecturer, Department of Epidemiology, Bangladesh University of Health Sciences (BUHS), Dhaka

*Corresponding Author: Tariqul Islam, Associate Professor, Department of Radiology and Imaging, Sheikh Hasina National Institute of Burn and Plastic Surgery, Dhaka.

Received: October 16, 2023; Published: October 26, 2023

Abstract

Background: Breast lump evaluation is pivotal in diagnosing breast diseases. This study examines diagnostic patterns, comparing ultrasonography (USG) and computed tomography (CT) guided procedures. Understanding their impact on histopathological outcomes is crucial for optimizing breast lump management.

Objective: To assess the diagnostic patterns in breast lump evaluation by comparing the histopathological findings of USG and CT guidance.

Methods: This prospective study included 221 participants with breast lumps who underwent diagnostic evaluation at the Sheikh Hasina National Institute of Burn and Plastic Surgery in Dhaka, Bangladesh, from June 2022 to August 2023. All participants underwent USG, and a subset underwent CT-guided biopsy. Demographic data, radiological diagnoses, and histopathological diagnoses were collected. Statistical analysis was accomplished using SPSS 26 software.

Result: Among respondents, 71.9% were aged 14-45 years, with a mean age of 38.64±13.48, and 93.7% were female. Core biopsy was the primary procedure (69.7% of cases), while FNAC was performed in 30.3% of cases. Carcinoma was the most common diagnosis (USG: 42.1%, CT: 35.3%). Lesions were distributed in the right breast (49.8%), left breast (40.3%), and both breasts (10.0%). A significant association between procedure type and histopathological diagnosis was found (p < 0.05). This study highlights the importance of selecting appropriate diagnostic methods for breast lumps and provides insights into diagnostic patterns.

Conclusion: Core biopsy is the preferred procedure for histopathological evaluation of breast lumps, as it has higher diagnostic accuracy for carcinoma and chronic metastasis than fine needle aspiration cytology (FNAC). CT guidance may be used in cases where USG is inconclusive, or the lesion is difficult to access.

 Keywords: Breast Lump; Ultrasonography; Computed Tomography; Histopathological Findings; Diagnostic Patterns; Procedure Choice; Radiological Diagnoses; Histopathological Diagnoses

References

  1. Brooks JD., et al. “Personalized risk assessment for prevention and early detection of breast cancer: integration and implementation (PERSPECTIVE I and I)”. Journal of Personalized Medicine6 (2021): 511.
  2. American College of Radiology. ACR practice guideline for the performance of breast biopsy. American College of Radiology (2022).
  3. American Cancer Society. Cancer Facts and Figures. Atlanta: American Cancer Society (2023).
  4. World Health Organization. Cancer. Geneva: World Health Organization (2023).
  5. Canadian Cancer Society. Canadian Cancer Statistics. Toronto: Canadian Cancer Society (2023).
  6. Statistics Canada. Table 13-10-0218-01: Deaths and age-standardized death rates for selected causes of death, Canada, provinces, territories, and health regions, annual (rate per 100,000 population). Ottawa: Statistics Canada (2023).
  7. Canadian Cancer Society. Economic burden of cancer in Canada. Toronto: Canadian Cancer Society (2023).
  8. Canadian Task Force on Preventive Health Care. Recommendation statement: breast cancer screening. Toronto: Canadian Task Force on Preventive Health Care (2023).
  9. American Cancer Society. Breast cancer screening and diagnosis.
  10. Liberman L and Dershaw DD. “Accuracy of core needle biopsy for the diagnosis of breast cancer: a systematic review and meta-analysis”. Journal of the National Cancer Institute 21 (2011): 1640-1649.
  11. Lee JH., et al. “CT-guided core needle biopsy of breast cancer: comparison with ultrasound-guided biopsy”. Korean Journal of Radiology6 (2011): 710-717.
  12. Wang Y., et al. “A meta-analysis of the diagnostic accuracy of computed tomography-guided core needle biopsy versus ultrasound-guided core needle biopsy for breast cancer”. Oncology Letters 5 (2017): 6115-6122.
  13. Wang Y., et al. “A meta-analysis comparing the diagnostic accuracy of CT-guided core needle biopsy and US-guided core needle biopsy in the diagnosis of breast cancer”. World Journal of Radiology3 (2022): 198.
  14. Wu MH., et al. “PET/CT-guided versus CT-guided percutaneous core biopsies in the diagnosis of bone tumors and tumor-like lesions: which is the better choice?” Cancer Imaging1 (2019): 1-2.
  15. Joudeh AA., et al. “Fine-needle aspiration followed by core-needle biopsy in the same setting: modifying our approach”. Acta Cytologica1 (2016): 1-3.

Citation

Citation: Tariqul Islam., et al. “The Neonates' Body Length and Body Weight in Two Different Periods of Time”.Acta Scientific Medical Sciences 7.11 (2023): 125-131.

Copyright

Copyright: © 2023 Tariqul Islam., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





Contact US